.svg){kind=small}
Jul-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Farmaceutical Rx (Frx) has shown notable performance shifts across various categories in Ohio. In the Edible category, the brand was not in the top 30 for April but saw a gradual improvement, ranking 39th in May, 37th in June, and 33rd in July. This upward trajectory indicates a growing acceptance and popularity of their edible products among consumers. However, the brand did not make it into the top 30 in July, which could be a point of concern or an area for strategic improvement. The Flower category showed a more consistent performance, with rankings fluctuating but remaining within the top 40, and even breaking into the top 30 by June. This suggests a strong foothold in the Flower market, though the slight dip in July might warrant closer examination.
In the Vapor Pens category, Farmaceutical Rx (Frx) did not secure a spot in the top 30 for June and July, which might indicate a challenge in this competitive segment. The brand was ranked 47th in April and dropped to 54th in May, showing a declining trend that could be detrimental if not addressed. Despite these fluctuations, the Flower category remains a bright spot, with sales peaking in June before a slight decline in July. This mixed performance across categories suggests that while Farmaceutical Rx (Frx) has strengths, particularly in Flower, there are areas like Vapor Pens that require strategic focus to enhance market presence.
Competitive Landscape
In the competitive landscape of the Ohio Flower category, Farmaceutical Rx (Frx) has shown a notable upward trend in its rankings over the past few months, moving from 38th place in April and May 2024 to 28th in June and 29th in July 2024. This improvement indicates a positive reception and growing market presence. However, Farmaceutical Rx (Frx) still faces stiff competition from brands like Standard Farms, which consistently ranked higher, peaking at 27th place in June before dropping to 32nd in July. Similarly, Matter. maintained a relatively stable position around the 30th mark, while The Standard showed strong performance, ranking as high as 19th in June before falling to 28th in July. Firelands Scientific also remained a formidable competitor, consistently ranking in the mid-20s. Despite these challenges, Farmaceutical Rx (Frx)'s significant sales increase from $97,179 in April to $223,194 in June demonstrates its potential for continued growth and market penetration.
Notable Products
In July 2024, the top-performing product from Farmaceutical Rx (Frx) was Strango (2.83g) in the Flower category, which achieved the number one rank with notable sales of 583 units. GG4 (5.66g) maintained its strong performance, holding the second rank consistently from June to July 2024. Red Headed Stranger (2.83g) emerged as the third highest-selling product in July 2024. Black Garlic Minis (14.15g) followed closely in fourth place. Neon Flamingo #6 (5.66g) saw a slight decline, dropping from third place in June to fifth place in July 2024.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
